Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
less decrease » mean decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
less decrease » mean decrease (Expand Search), teer decrease (Expand Search), we decrease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
81
-
82
Univariate and multivariable analyses for OS.
Published 2025“…<div><p>Background</p><p>Lung carcinma, a serious disease commonly recognized at advanced stages and has less favorable outcomes to treatments. …”
-
83
Characteristics of LC patients.
Published 2025“…<div><p>Background</p><p>Lung carcinma, a serious disease commonly recognized at advanced stages and has less favorable outcomes to treatments. …”
-
84
Flowchart of this study.
Published 2025“…<div><p>Background</p><p>Lung carcinma, a serious disease commonly recognized at advanced stages and has less favorable outcomes to treatments. …”
-
85
-
86
-
87
-
88
-
89
Demographic characteristics of the participants.
Published 2025“…The mean patient age was 56 years, and 12 patients were women (28%). A significant decrease in all HRQOL subscale scores was observed in the homonymous hemianopia and monocular blindness groups. …”
-
90
Data file.
Published 2025“…The mean patient age was 56 years, and 12 patients were women (28%). A significant decrease in all HRQOL subscale scores was observed in the homonymous hemianopia and monocular blindness groups. …”
-
91
-
92
Neutralization with additional bevacizumab to serum samples pre- and post-bevacizumab administration.
Published 2024“…<b>c</b> Further addition of bevacizumab to serum samples post-bevacizumab administration significantly decreased VEGF-A121 levels in samples to which 20 and 200 μg/mL bevacizumab was added (ANOVA: <i>p</i> < 0.0001; Dunnett’s multiple comparisons test: +2 μg/mL, <i>p</i> = 0.7096 vs control; +20 μg/mL, <i>p</i> = 0.0107 vs control; +200 μg/mL, <i>p</i> < 0.0001 vs control). …”
-
93
-
94
-
95
-
96
-
97
-
98
Primers used for qPCR gene expression analysis.
Published 2025“…Despite its significance, the role of SLC2A2 in liver differentiation and hepatocellular carcinoma (HCC) remains underexplored. …”
-
99
-
100